HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xin Wang Selected Research

lactobionic acid (lactobionate)

8/2018Bromelain-immobilized and lactobionic acid-modified chitosan nanoparticles for enhanced drug penetration in tumor tissues.
7/2018Acid-degradable lactobionic acid-modified soy protein nanogels crosslinked by ortho ester linkage for efficient antitumor in vivo.
9/2017Acid-degradable carboxymethyl chitosan nanogels via an ortho ester linkage mediated improved penetration and growth inhibition of 3-D tumor spheroids in vitro.
1/2017Bromelain-decorated hybrid nanoparticles based on lactobionic acid-conjugated chitosan for in vitro anti-tumor study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xin Wang Research Topics

Disease

1004Neoplasms (Cancer)
12/2022 - 01/2002
188Neoplasm Metastasis (Metastasis)
12/2022 - 02/2004
186Inflammation (Inflammations)
12/2022 - 04/2003
163Breast Neoplasms (Breast Cancer)
10/2022 - 04/2002
160Infections
08/2022 - 05/2002
103Stomach Neoplasms (Stomach Cancer)
11/2022 - 01/2002
94Carcinogenesis
10/2022 - 10/2002
91Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2022 - 08/2002
89Alzheimer Disease (Alzheimer's Disease)
10/2022 - 09/2006
87Colorectal Neoplasms (Colorectal Cancer)
12/2022 - 02/2004
74Hypertension (High Blood Pressure)
10/2022 - 06/2002
67Lung Neoplasms (Lung Cancer)
11/2022 - 07/2009
67Carcinoma (Carcinomatosis)
05/2022 - 10/2004
59Stroke (Strokes)
06/2022 - 06/2003
59Fibrosis (Cirrhosis)
02/2022 - 04/2002
58Hypoxia (Hypoxemia)
07/2022 - 12/2003
57Hepatocellular Carcinoma (Hepatoma)
07/2022 - 08/2008
50Wounds and Injuries (Trauma)
06/2022 - 04/2004
47Prostatic Neoplasms (Prostate Cancer)
04/2022 - 04/2002
46COVID-19
07/2022 - 01/2020
46Cardiovascular Diseases (Cardiovascular Disease)
04/2022 - 01/2007
45Body Weight (Weight, Body)
10/2022 - 08/2005
43Cognitive Dysfunction
10/2022 - 06/2012
42Colonic Neoplasms (Colon Cancer)
03/2022 - 05/2005
40Esophageal Squamous Cell Carcinoma
11/2022 - 01/2009
40Obesity
10/2022 - 12/2007
39Insulin Resistance
08/2022 - 11/2005
39Type 2 Diabetes Mellitus (MODY)
04/2022 - 01/2007
38Myocardial Infarction
10/2022 - 07/2006
37Pain (Aches)
01/2022 - 09/2003
36Hemorrhage
05/2022 - 10/2005
36Atherosclerosis
01/2022 - 03/2003
34Ischemia
07/2022 - 12/2003
33Glioma (Gliomas)
07/2021 - 04/2004
32Osteosarcoma (Osteogenic Sarcoma)
01/2022 - 11/2012
32Reperfusion Injury
12/2021 - 10/2010
31Heart Failure
01/2022 - 03/2003
30Rheumatoid Arthritis
05/2022 - 10/2011
29Ischemic Stroke
06/2022 - 06/2011
29Epilepsy (Aura)
05/2022 - 12/2011
29Lymphatic Metastasis
11/2021 - 06/2008
28Mitochondrial Diseases (Mitochondrial Disease)
08/2022 - 02/2008
28Leukemia
03/2022 - 02/2005
27Neurodegenerative Diseases (Neurodegenerative Disease)
10/2022 - 01/2009
27Infarction (Infarctions)
12/2021 - 02/2008
26Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 01/2008
26Adenocarcinoma
01/2022 - 08/2002
26Lymphoma (Lymphomas)
01/2022 - 01/2002
25Ovarian Neoplasms (Ovarian Cancer)
12/2022 - 01/2014
25Rectal Neoplasms (Rectal Cancer)
11/2022 - 07/2009

Drug/Important Bio-Agent (IBA)

332Proteins (Proteins, Gene)FDA Link
11/2022 - 01/2002
226Pharmaceutical PreparationsIBA
08/2022 - 07/2002
180Biomarkers (Surrogate Marker)IBA
11/2022 - 09/2008
109Biological ProductsIBA
12/2022 - 08/2004
107MicroRNAs (MicroRNA)IBA
11/2022 - 01/2008
96Messenger RNA (mRNA)IBA
12/2022 - 02/2002
91CytokinesIBA
10/2022 - 05/2002
76Glucose (Dextrose)FDA LinkGeneric
10/2022 - 09/2005
69EnzymesIBA
10/2022 - 04/2003
62Long Noncoding RNAIBA
12/2022 - 01/2015
59RNA (Ribonucleic Acid)IBA
11/2022 - 02/2005
55LipidsIBA
10/2022 - 09/2004
55Therapeutic UsesIBA
06/2022 - 06/2007
54DNA (Deoxyribonucleic Acid)IBA
03/2022 - 04/2002
52Interleukin-6 (Interleukin 6)IBA
01/2022 - 05/2002
51VaccinesIBA
08/2022 - 04/2005
48Small Interfering RNA (siRNA)IBA
06/2022 - 03/2007
46Peptides (Polypeptides)IBA
10/2022 - 07/2004
45CateninsIBA
06/2022 - 09/2010
44Doxorubicin (Adriamycin)FDA LinkGeneric
03/2022 - 07/2002
42Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2022 - 05/2004
38ErbB Receptors (EGF Receptor)IBA
12/2022 - 08/2004
38Oxygen (Dioxygen)IBA
07/2022 - 02/2004
38Indicators and Reagents (Reagents)IBA
05/2022 - 02/2004
37Amyloid (Amyloid Fibrils)IBA
10/2022 - 01/2008
37LigandsIBA
06/2022 - 08/2002
33AntigensIBA
12/2022 - 05/2005
32Cisplatin (Platino)FDA LinkGeneric
12/2022 - 07/2002
32Reactive Oxygen Species (Oxygen Radicals)IBA
11/2022 - 09/2004
32Insulin (Novolin)FDA Link
10/2022 - 05/2008
32CollagenIBA
01/2022 - 09/2004
31Transcription Factors (Transcription Factor)IBA
01/2022 - 05/2002
30AntioxidantsIBA
10/2022 - 06/2010
29Circular RNAIBA
08/2022 - 01/2016
28CholesterolIBA
09/2022 - 08/2010
28Anti-Bacterial Agents (Antibiotics)IBA
08/2022 - 01/2004
28Phosphotransferases (Kinase)IBA
01/2022 - 04/2009
25Monoclonal AntibodiesIBA
12/2022 - 04/2007
25Protein Isoforms (Isoforms)IBA
12/2021 - 07/2008
25Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 05/2002

Therapy/Procedure

453Therapeutics
10/2022 - 04/2002
157Drug Therapy (Chemotherapy)
10/2022 - 02/2006
116Radiotherapy
06/2022 - 01/2009
59Immunotherapy
06/2022 - 09/2006
40Chemoradiotherapy
03/2022 - 12/2011
34Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 05/2004
33Transplantation
12/2022 - 06/2006
31Lasers (Laser)
03/2022 - 01/2002
27Neoadjuvant Therapy
03/2022 - 03/2015
25Length of Stay
03/2022 - 06/2005